Sign Up to like & get
recommendations!
0
Published in 2019 at "Clinical Pharmacology in Drug Development"
DOI: 10.1002/cpdd.685
Abstract: Doravirine is a novel nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus type‐1 (HIV‐1) infection. In vitro and clinical data suggest that doravirine is unlikely to cause significant drug–drug interactions via major…
read more here.
Keywords:
doravirine;
coadministration doravirine;
drug;
following coadministration ... See more keywords